|
2025
|
Invention
|
Lyophilized resiniferatoxin.
The invention relates to a reconstitutable solid pharmaceutical com... |
|
|
Invention
|
Ethanolic resiniferatoxin concentrate.
The invention relates to a liquid pharmaceutical concentr... |
|
|
Invention
|
Treating knee joint pain by injecting resiniferatoxin at ultra low doses.
The invention relates ... |
|
2024
|
Invention
|
Resiniferatoxin compositions.
Disclosed are non-aqueous solid and liquid compositions comprising... |
|
|
Invention
|
Further substituted triazolo quinoxaline derivatives.
The present invention relates to compounds... |
|
|
Invention
|
Cis-8-(3,5-difluorophenyl)-8-(dimethylamino)-1,3-diazaspiro[4.5]decan-2-one derivatives.
The inv... |
|
2023
|
Invention
|
Sulfoximines as inhibitors of nav1.8.
Compounds according to general formula (I)
Compounds acc... |
|
|
Invention
|
3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
The invention relates t... |
|
|
Invention
|
8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
The invention relates to 8-amino-2-oxo-1... |
|
|
Invention
|
3-((hetero-)aryl)-alkyl-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
The invention re... |
|
|
Invention
|
3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
The invention relates ... |
|
|
Invention
|
Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride.... |
|
2022
|
Invention
|
3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
The invention relates ... |
|
|
Invention
|
Score tablet.
A scored tablet comprises Tapentadol or a physiologically acceptable salt thereof ... |
|
|
Invention
|
Quinoxaline derivatives.
The present invention relates to compounds according to general formula... |
|
|
Invention
|
Substituted pyrazole amides. The present invention relates to compounds according to general form... |
|
|
Invention
|
Tapentadol for treating neuropathic pain in covid-19 patients.
The invention relates to a pharma... |
|
|
Invention
|
Substituted pyrrolidine amides ii. The invention relates to compounds according to general formul... |
|
2021
|
Invention
|
Substituted pyrrolidine amides iv.
The invention relates to compounds according to general formu... |
|
|
Invention
|
Substituted pyrrolidine amides v. The invention relates to compounds according to general formula... |
|
|
Invention
|
Composition comprising capsaicin or a capsacinoid for postoperative pain control.
A composition ... |
|
|
Invention
|
Substituted pyrrolidine amines and amides vi.
The invention relates to compounds according to ge... |
|
|
Invention
|
Treatment of irritable bowel syndrome.
A method of treating irritable bowel syndrome in a patien... |
|
|
Invention
|
Repeated topical application of capsaicin patch for treating initial non-responders.
The inventi... |
|
|
Invention
|
Further substituted triazolo quinoxaline derivatives. The present invention relates to compounds ... |
|
|
Invention
|
Substituted triazolo quinoxaline derivatives. The present invention relates to compounds accordin... |
|
|
Invention
|
Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol. The pr... |
|
2020
|
Invention
|
Protecting oral overdose with abuse deterrent immediate release formulations.
The invention rela... |
|
|
Invention
|
Abuse-proofed oral dosage form. The present invention relates to an abuse-proofed, oral dosage fo... |
|
|
Invention
|
Abuse-proofed dosage form.
A solid administration form, protected from parenteral abuse and cont... |
|
|
Invention
|
Tamper-resistant dosage form with immediate release and resistance against solvent extraction.
A... |
|
|
Invention
|
1,3-diaza-spiro-[3.4]-octane derivatives.
The invention relates to 1,3-diaza-spiro-[3.4]-octane ... |
|
|
Invention
|
Process for the preparation of (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol.
The p... |
|
|
Invention
|
Substituted pyrrolidine amides iii. The invention relates to compounds according to general formu... |
